1Verin V,Urban P,Popowski Y,et al.Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty: a clinical pilot study[].Circulation.1997
2Verin V,Popowski Y,Urban P,et al.Intra-arterial beta irridiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model[].Circulation.1995
3Yu CC,Fletcher CD,Newman PL,et al.A comparison of proliferating cell nuclear antige ( PCNA) immunostaining, nucleolar organizer region ( AgNOR ) staining and histological grading in gastroinstestinal stromal tumours[].Journal of Paleopathology.1992
4Condado JA,Waksman R,Gurdierl O,et al.Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans[].Circulation.1997
5Amols HI,Reinstein LE,Weinberger J,et al.Radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia[].Medical Physics.1996
6Waksman R,White RL,Chan RC,et al.Localized intracoronary radiation therapy for patients with in-stent restenosis:preliminary results from a randomized clinical study ( Abstract)[].Circulation.1997
7Mazur W,Ali MN,Dabaghi SF,et al.High dose rate intracoronary irradiation suppresses neointimal proliferation in the stented and ballooned model of porcine restenosis[].International Journal of Radiation Oncology Biology Physics.1996
8King SB Ⅲ,Williams DO,Prakash Chougule J,et al.Endovascular beta radiation to reduce restenosis after coronary balloon angioplasty: result of the beta energy restenosis trial ( BERT)[].Circulation.1998
9Waksman R,Robinson KA,Crocker IR,et al.Endovascular low dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiationt therapy in restenosis prevention[].Circulation.1995
1Mann MJ,Gibbons GH,Kernoff RS.Genetic engineering of vein grafts resistant to atherosclerosis[J].Proc Natl Acad Sci USA,1995,92:4502-4506.
2Shimokawa K,Katayama M,Matsuda Y,et al.Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma[J].Mol Human Reprod,2002,8:32-36.
3Dambrin C,Klupp J,Birsan T,et al.Sirolimus (Rapamycin) monotherapy prevents graft vascular disease in nonhuman primate recipients of orthotopic aortic allografts[J].Circulation,2003,107:2369-2374.
4Legare JF,Issekutz T,Lee TDG,et al.CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection[J].Am J Pathol,2000,157:859-865.
5Brew K,Dinakarpandian D,Nagase H.Tissue inhibitors of metalloproteinases:evolution,structure and function[J].Biochim Biophys Acta,2000,1477:267-283.
6Solomon A,Li DQ,Lee SB,et al.Regulation of collagenase,stromelysin,and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines[J].Invest Ophthalmol Vis Sci,2000,41:2154-2163.
7Farina AR,Coppa A,Tiberio A,et al.Transforming growth factor-betal enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity[J].Int J Cancer,1998,75:721-730.
8Bond M,Murphy G,Bennett MR,et al.Tissue inhibitor of metalloproteinase-3 induces a fas-associated death domain-dependent type Ⅱ apoptotic pathway[J].J Biol Chem,2002,277:13787-13795.
